A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
Condition(s):Small Cell Lung Cancer (SCLC)Last Updated:July 14, 2014Terminated
Hide Studies Not Open or Pending
Condition(s):Small Cell Lung Cancer (SCLC)Last Updated:July 14, 2014Terminated
Condition(s):Small Cell Lung CancerLast Updated:October 5, 2018Terminated
Condition(s):Small-cell Lung CancerLast Updated:August 15, 2023Completed
Condition(s):Small Cell Lung CancerLast Updated:January 12, 2024Not yet recruiting
Condition(s):Small Cell Lung Cancer Extensive StageLast Updated:December 9, 2020Unknown status
Condition(s):Small-cell Lung CancerLast Updated:April 12, 2022Terminated
Condition(s):Small Cell Lung CancerLast Updated:May 2, 2011Terminated
Condition(s):Small Cell Lung Cancers; Neuroendocrine CarcinomaLast Updated:January 3, 2024Recruiting
Condition(s):Small Cell Lung CarcinomaLast Updated:June 25, 2018Terminated
Condition(s):Extensive Stage Small Cell Lung CancerLast Updated:September 30, 2022Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.